Linezolid Accord Healthcare

Linezolid, the active ingredient in Linezolid Accord Healthcare, is an oxazolidinone antibiotic presented as an oral tablet for oral use. It treats infections caused by susceptible Gram‑positive bacteria, including methicillin‑resistant Staphylococcus aureus (MRSA) and vancomycin‑resistant Enterococcus (VRE), in adult patients.

GNH USA supplies Linezolid Accord Healthcare as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance and regulatory compliance. Our distribution network ensures reliable delivery to healthcare providers across Europe, Asia, Africa and the Americas.

Linezolid is an oxazolidinone antibiotic used to treat infections caused by susceptible Gram‑positive bacteria.

- Skin and soft tissue infections: reduces bacterial load and promotes healing of infected lesions. - Community‑acquired pneumonia: eradicates causative Gram‑positive pathogens and improves respiratory function. - Nosocomial pneumonia: effective against hospital‑acquired Gram‑positive lung infections, aiding recovery. - Infections caused by MRSA and VRE: provides targeted activity against resistant strains, helping to resolve severe infections.

Linezolid may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea - Diarrhea - Headache - Metallic taste - Vomiting - Rash

Serious or Rare Side Effects: - Thrombocytopenia - Anemia - Peripheral neuropathy - Serotonin syndrome - Myelosuppression - Lactic acidosis

Use of linezolid requires careful clinical monitoring to minimize risks.

- Renal impairment: assess renal function and monitor for accumulation. - Hepatic impairment: evaluate liver enzymes before and during therapy. - Concomitant serotonergic drugs: avoid due to risk of serotonin syndrome. - Hematologic monitoring: perform regular complete blood counts. - Pregnancy and lactation: safety not established; weigh benefits against potential risks. - Store at room temperature: keep in the original packaging, protect from moisture and heat.

Linezolid interacts with several drug classes; awareness of these interactions helps ensure safe use.

Major Interactions (Avoid): - SSRIs and SNRIs: increased risk of serotonin syndrome. - MAO inhibitors: may precipitate serotonin syndrome. - Rifampin: reduces linezolid plasma concentrations. - Warfarin: potentiates anticoagulant effect, increasing bleeding risk.

Moderate Interactions (Monitor Closely): - NSAIDs: may enhance gastrointestinal irritation. - Diuretics: potential for additive hypotensive effect. - Anticonvulsants (e.g., phenytoin): possible alteration of linezolid levels.